Type 1 diabetes represents an attractive target for human embryonic stem cell (hESC)-based cell replacement therapies. Recently, in Nature Biotechnology, Kroon et al. (2008) reported encouraging progress toward this goal with the development of functional islet-like structures in mice transplanted with hESC-derived pancreatic endoderm.
|Pages (from-to)||300 - 301|
|Number of pages||2|
|Journal||Cell Stem Cell|
|Publication status||Published - 2008|